• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Average number of MedSun reports submitted per hospital during the month

Dictionary: Medical Product Safety Network (MedSun) is an adverse event reporting network of 350 hospitals established to facilitate the identification, comprehension, and resolution of adverse events due to problems with the use of medical devices. Participants use an Internet-based system that is designed to be an easy and secure way to report adverse medical device events. MedSun is an invaluable tool that aids in identifying unexpected side effects of devices that were not observed during the premarket testing, and in identifying an increase in the number of expected problems. This measure is an indicator of whether participating sites are effectively submitting reports.

Fiscal Year - 2011

Skip graphic and jump to text data

Oct 2010N/A3.5
Nov 2010N/A2.9
Dec 2010N/A3.0
Jan 2011N/A3.1
Feb 2011N/A2.5
Mar 2011N/A3.0
Apr 2011N/A2.9
May 2011N/A3.0
Jun 2011N/A2.6
Jul 2011N/A3.2
Aug 2011N/A3.3
Sep 2011N/A3.0

Number of MedSun reports submitted during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

Oct 2010N/A398
Nov 2010N/A373
Dec 2010N/A422
Jan 2011N/A349
Feb 2011N/A301
Mar 2011N/A465
Apr 2011N/A421
May 2011N/A421
Jun 2011N/A367
Jul 2011N/A436
Aug 2011N/A445
Sep 2011N/A384

Number of MedSun hospitals that submitted reports during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

Oct 2010N/A115
Nov 2010N/A130
Dec 2010N/A139
Jan 2011N/A112
Feb 2011N/A120
Mar 2011N/A154
Apr 2011N/A146
May 2011N/A141
Jun 2011N/A142
Jul 2011N/A137
Aug 2011N/A135
Sep 2011N/A128


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.